Patient Guide: A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 41 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05322577
Status: 🟢 Enrolling Now
Condition: Stomach Neoplasms
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 41 locations across the country.

Top locations include:
  • • Northport, New York
  • • Toyoake-shi, Aichi
  • • Hirosaki-shi, Aomori
  • • And 38 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer. - Join Clinical Trial NCTNCT05322577

How to Join This Clinical Trial - NCTNCT05322577

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Stomach Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Stomach Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Stomach Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05322577 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 41 locations. Find a study site near you:

Clinical Research Site

Northport, New York 11768 - United States

Status: TERMINATED

Clinical Research Site

Toyoake-shi, Aichi 470-1192 - Japan

Status: RECRUITING

Clinical Research Site

Hirosaki-shi, Aomori 036-8563 - Japan

Status: RECRUITING

Clinical Research Site

Chiba-shi, Chiba 260-8677 - Japan

Status: RECRUITING

Clinical Research Site

Matsuyama-shi, Ehime 791-0280 - Japan

Status: RECRUITING

Clinical Research Site

Fukui-Shi, Fukui 910-8526 - Japan

Status: RECRUITING

Clinical Research Site

Fukuoka-shi, Fukuoka 812-8582 - Japan

Status: RECRUITING

Clinical Research Site

Fukushima-shi, Fukushima 960-1295 - Japan

Status: RECRUITING

Clinical Research Site

Gifu-shi, Gifu 501-1194 - Japan

Status: RECRUITING

Clinical Research Site

Ogaki-shi, Gifu 503-8502 - Japan

Status: TERMINATED

And 31 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Stomach Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships